Northern Trust
KPRX icon

Northern Trust’s Kiora Pharmaceuticals KPRX Stock Holding History

Northern Trust’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3
Closed -$3K – 4273
2019
Q2 		$3K Hold
3
– – ﹤0.01% 4246
2019
Q1 		$4K Hold
3
– – ﹤0.01% 4202
2018
Q4 		$7K Hold
3
– – ﹤0.01% 4221
2018
Q3 		$5K Hold
3
– – ﹤0.01% 4276
2018
Q2 		$8K Hold
3
– – ﹤0.01% 4260
2018
Q1 		$6K Hold
3
– – ﹤0.01% 4217
2017
Q4 		$16K Buy
3
+1
+50% +$6.18K ﹤0.01% 4170
2017
Q3 		$13K Buy
+2
New +$12.7K ﹤0.01% 4183

Other funds holding KPRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
GSWM
Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Northern Trust's KPRX Position: Q3 2019 in Review

Northern Trust sold out of Kiora Pharmaceuticals (KPRX) in Q3 2019, closing a stake of 3 shares — an estimated $3K sold.

Northern Trust first reported a position in KPRX in Q3 2017 and held it in 8 quarters. The position peaked at $16K in Q4 2017. 9 funds tracked by Wall St. Rank hold KPRX as of Q3 2019.

  • Northern Trust reported no remaining Kiora Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Northern Trust sold 3 Kiora Pharmaceuticals shares in Q3 2019, an estimated $3K.
  • Northern Trust first reported a position in Kiora Pharmaceuticals in Q3 2017 and held it in 8 quarters.
  • Northern Trust's Kiora Pharmaceuticals position peaked at $16K in Q4 2017.
  • 9 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q3 2019.

Based on Northern Trust's 13F filing for Q3 2019, filed 13 Nov 2019.